• 1968 Citations
  • 25 h-Index
20042019
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 6 Similar Profiles
Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Confidence Intervals Medicine & Life Sciences
Venous Thromboembolism Medicine & Life Sciences
Low Molecular Weight Heparin Medicine & Life Sciences
Male Breast Neoplasms Medicine & Life Sciences
Heparin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 1968 Citations
  • 25 h-Index
  • 118 Article
  • 9 Review article
  • 1 Comment/debate

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

Gamucci, T., Pizzuti, L., Natoli, C., Mentuccia, L., Sperduti, I., Barba, M., Sergi, D., Iezzi, L., Maugeri-Saccà, M., Vaccaro, A., Magnolfi, E., Gelibter, A., Barchiesi, G., Magri, V., D’Onofrio, L., Cassano, A., Rossi, E., Botticelli, A., Moscetti, L., Omarini, C. & 29 othersFabbri, M. A., Scinto, A. F., Corsi, D., Carbognin, L., Mazzotta, M., Bria, E., Foglietta, J., Samaritani, R., Garufi, C., Mariani, L., Barni, S., Mirabelli, R., Sarmiento, R., Graziano, V., Santini, D., Marchetti, P., Tonini, G., Di Lauro, L., Sanguineti, G., Paoletti, G., Tomao, S., De Maria, R., Veltri, E., Paris, I., Giotta, F., Latorre, A., Giordano, A., Ciliberto, G. & Vici, P., Feb 1 2019, In : Cancer Biology and Therapy. 20, 2, p. 192-200 9 p.

Research output: Contribution to journalArticle

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

Gamucci, T., Pizzuti, L., Natoli, C., Mentuccia, L., Sperduti, I., Barba, M., Sergi, D., Iezzi, L., Maugeri-Saccà, M., Vaccaro, A., Magnolfi, E., Gelibter, A., Barchiesi, G., Magri, V., D'Onofrio, L., Cassano, A., Rossi, E., Botticelli, A., Moscetti, L., Omarini, C. & 29 othersFabbri, M. A., Scinto, A. F., Corsi, D., Carbognin, L., Mazzotta, M., Bria, E., Foglietta, J., Samaritani, R., Garufi, C., Mariani, L., Barni, S., Mirabelli, R., Sarmiento, R., Graziano, V., Santini, D., Marchetti, P., Tonini, G., Di Lauro, L., Sanguineti, G., Paoletti, G., Tomao, S., De Maria, R., Veltri, E., Paris, I., Giotta, F., Latorre, A., Giordano, A., Ciliberto, G. & Vici, P., Nov 7 2018, In : Cancer Biology and Therapy. p. 1-9 9 p.

Research output: Contribution to journalArticle

7 Citations

Anticoagulation for people with cancer and central venous catheters

Kahale, L. A., Tsolakian, I. G., Hakoum, M. B., Matar, C. F., Barba, M., Yosuico, V. E. D., Terrenato, I., Sperati, F., Schünemann, H. & Akl, E. A., Jun 1 2018, In : Cochrane Database of Systematic Reviews. 2018, 6, p. CD006468

Research output: Contribution to journalReview article

Central Venous Catheters
Confidence Intervals
Low Molecular Weight Heparin
Vitamin K
Neoplasms

Anticoagulation for perioperative thromboprophylaxis in people with cancer

Matar, C. F., Kahale, L. A., Hakoum, M. B., Tsolakian, I. G., Etxeandia-Ikobaltzeta, I., Yosuico, V. E., Terrenato, I., Sperati, F., Barba, M., Schünemann, H. & Akl, E. A., Jul 11 2018, In : Cochrane Database of Systematic Reviews. 2018, 7, p. CD009447

Research output: Contribution to journalReview article

4 Citations

Anticoagulation for the initial treatment of venous thromboembolism in people with cancer

Hakoum, M. B., Kahale, L. A., Tsolakian, I. G., Matar, C. F., Yosuico, V. E. D., Terrenato, I., Sperati, F., Barba, M., Schünemann, H. & Akl, E. A., Jan 24 2018, In : Cochrane Database of Systematic Reviews. 2018, 1, p. CD006649

Research output: Contribution to journalReview article

Venous Thromboembolism
Confidence Intervals
Low Molecular Weight Heparin
Neoplasms
Odds Ratio